Heart transplant clinical trial expands access to lifesaving medicine

Heart transplant clinical trial expands access to lifesaving medicine

A new medical technology expected to be on the market in 2027 is poised to help patients in middle America have greater access to heart transplants.  Xvivo Perfusion, a leader in organ transplant technology, is close to publishing clinical trial results for a new product that keeps hearts viable for longer after they have been retrieved from a deceased donor. The demand for heart transplants significantly outpaces supply. Eighteen new heart pati…